A Prospective, Multi-Center, Randomized, Controlled Clinical Trial to Explore the Role of Mesenchymal Stem Cells in Preventing Graft Versus Host Disease
Han Yao(Army Medical University), Xi Zhang(Army Medical University), Yimei Feng(Xinqiao Hospital), Lidan Zhu(Army Medical University), Ruihao Huang(Army Medical University), Peiyan Kong(Army Medical University), Li Gao(Army Medical University), Xiaoqi Wang(Army Medical University), Lu Wang(Harbin Medical University), Jia Liu(Nanjing Medical University), Ting Chen(China Medical University), Lu Zhao(Liaoning Provincial People's Hospital), Xiaohui Zhang(Peking University), Yuqing Liu(Guangdong Pharmaceutical University), Cheng Zhang(Army Medical University), Hai‐Xia Fu(Peking University), Lei Gao(Second Military Medical University), Ren Lin(Nanfang Hospital), Xiaojuan Deng(Army Medical University), Qifa Liu(Nanfang Hospital)
Cited by 1
Related Papers
Recent advances in CAR-T cell engineering
|Journal of Hematology & Oncology|2020|403
Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China
|Journal of Hematology & Oncology|2017|256
Genomic and Transcriptomic Characterization of Natural Killer T Cell Lymphoma
|Cancer Cell|2020|234
TET2 Function in Hematopoietic Malignancies, Immune Regulation, and DNA Repair
|Frontiers in Oncology|2019|115
Conditional deletion of Mecp2 in parvalbumin-expressing GABAergic cells results in the absence of critical period plasticity
|Nature Communications|2014|114